The cost of depression in the elderly. Effects of drug therapy

Drugs and Aging

Volumn 10, Issue 1, 1997, Pages 59-68

  Hughes, David ^a   Morris, Stephen ^a   McGuire, Alistair ^a,b  

^a CITY UNIVERSITY   (United Kingdom)

^b WOLFSON COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG COST; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031027213     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199710010-00006     Document Type: Review

References (26)

1. West R. Depression. London: Office of Health Economics, 1992
2. Angst J. Epidemiology of depression. Psychopharmacology 1992; 106 Suppl.: S71-4
3. Copeland JR, Davidson IA, Dewey ME, et al. Alzheimer's disease other dementias, depression and pseudo-dementia: prevalence, incidence and three year outcome in Liverpool. Br J Psychiatry 1992; 161: 230-9
4. Iliffe S, Haines A, Gallivan S, et al. Assessment of elderly people in general practice. Br J Gen Pract 1991; 41: 9-12
5. MacDonald AJ. Do general practitioners miss depression in elderly patients? BMJ 1986; 292: 1365-7
6. Katona CL. Approaches to the management of depression in old age. Gerontology 1994; 40 Suppl. 1: 5-9
7. Stoudemire A, Frank R, Hedemark N, et al. The economic burden of depression. Gen Hosp Psychiatry 1986; 8: 387-94
8. Greenberg PE, Stiglin LE, Finkelstein SN. The economic burden of depression in 1990. J Clin Psychiatry 1993; 54: 405-18
9. Kind P, Sorensen J. The costs of depression. Int Clin Psychopharmacol 1993; 7: 191-5
10. Rice DP, Miller LS. The economic burden of affective disorders. Br J Psychiatry 1995; 166 Suppl. 27: 34-42
11. Katona CL. Rationalising antidepressants for elderly people. Int Clin Psychopharmacol 1995; 10 Suppl. 1: 37-40
12. Georgotas A, McCue RE, Cooper TB, et al. How effective and safe is continuation therapy in elderly depressed patients? Arch Gen Psychiatry 1988; 45: 929-32
13. Old Age Depression Interest Group. How long should the elderly take antidepressants? A double blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Br J Psychiatry 1993; 162: 175-82
14. Feighner JP, Cohn JB. Double blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 1985; 46: 20-5
15. Guze BH, Freedman DX. Psychiatry. JAMA 1991; 265: 3164-5
16. Reynolds CF. Treatment of depression in late life. Am J Med 1994; 97 Suppl. 6A: 39S-46S
17. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. New York: Oxford University Press, 1988
18. Boyer WF, Feighner JP. The financial implications of starting treatment with a selective serotonin reuptake inhibitor or tricyclic antidepressant in drug-naive depressed patients. In: Jönsson B, Rosenbaum J, editors. Health economics of depression. Chichester: Wiley, 1993: 65-76
19. Song F, Freemantle N, Sheldon TA, et al. Selective serotonin reuptake inhibitors: meta analysis of efficacy and acceptability. BMJ 1993; 306: 683-7
20. McGuire A, Hughes D. The economic evaluation of depression. Postgrad Med J 1994; 70 Suppl. 2: S14-22
21. Jönsson B, Bebbington PE. Economic studies of the treatment of depressive illness. In: Jönsson B, Rosenbaum J, editors. Health economics of depression. Chichester: Wiley, 1993: 35-48
22. Kamlet MS, Wade M, Kupfer DJ, et al. Cost-utilily analysis of maintenance treatment for recurrent depression: a theoretical framework and numerical illustration. In: Frank R, Manning WG, editors. Economics and mental health. Baltimore (MD): Johns Hopkins University Press, 1992; 265-91
23. Hatziandreu EJ, Brown RE, Revicki DA, et al. Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin. PharmacoEconomics 1994; 5: 249-64
24. Lane R, MacDonald G. Reducing the economic burden of depression. Int Clin Psychopharmacol 1995; 9: 229-43
25. Murphy E, Smith R, Lindesay J, et al. Increased mortality in late-life depression. Br J Psychiatry 1988; 152: 347-53
26. Rosenbaum JF. Clinical choices, cost-effectiveness and antidepressant treatments. In: Jönsson B, Rosenbaum J, editors. Health economics of depression. Chichester: Wiley, 1993: 141-8